January 19, 2026

Uncategorized

New Releases from NCBI BookshelfNivolumab Plus Ipilimumab (Opdivo Plus Yervoy): Indication: Opdivo (nivolumab), in combination with ipilimumab, for the first-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma: Reimbursement Recommendation [Internet].​Nivolumab Plus Ipilimumab (Opdivo Plus Yervoy): Indication: Opdivo (nivolumab), in combination with ipilimumab, for the first-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma: Reimbursement Recommendation [Internet].

What Is the Reimbursement Recommendation for Opdivo Plus Yervoy? ​ 

Uncategorized

New Releases from NCBI BookshelfComparing Two Ways of Supporting Mental Health among Clinicians, Staff, and Patients during the COVID-19 Pandemic—The MHAPPS Study [Internet].​Comparing Two Ways of Supporting Mental Health among Clinicians, Staff, and Patients during the COVID-19 Pandemic—The MHAPPS Study [Internet].

The COVID-19 pandemic has dramatically affected individuals and communities, with implications for both mental and physical health. The mental health

Scroll to Top